ProKidney Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Bruce Culleton
Chief executive officer
US$9.0m
Total compensation
| CEO salary percentage | 2.7% |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
We're Hopeful That ProKidney (NASDAQ:PROK) Will Use Its Cash Wisely
Nov 18
We're Not Very Worried About ProKidney's (NASDAQ:PROK) Cash Burn Rate
Aug 12We Think ProKidney (NASDAQ:PROK) Can Afford To Drive Business Growth
May 12Here's Why We're Not Too Worried About ProKidney's (NASDAQ:PROK) Cash Burn Situation
Nov 17ProKidney (NASDAQ:PROK) Is In A Strong Position To Grow Its Business
Mar 14ProKidney reports Q2 2022 results
Aug 11CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$46m |
| Jun 30 2024 | n/a | n/a | -US$39m |
| Mar 31 2024 | n/a | n/a | -US$35m |
| Dec 31 2023 | US$9m | US$245k | -US$35m |
Compensation vs Market: Bruce's total compensation ($USD9.00M) is above average for companies of similar size in the US market ($USD2.18M).
Compensation vs Earnings: Insufficient data to compare Bruce's compensation with company performance.
CEO
Bruce Culleton (56 yo)
less than a year
Tenure
US$9,003,399
Compensation
Dr. Bruce Culleton, M.D., is Chief Executive Officer and Director at ProKidney Corp. since November 15, 2023. He was Executive Vice President of Clinical Development & Commercialization of ProKidney Corp....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$9.00m | no data | |
| Founder | no data | US$7.58m | 0% $ 0 | |
| Chief Financial Officer | 2.8yrs | US$2.29m | 0% $ 0 | |
| Chief Legal Officer & Secretary | 2.7yrs | US$2.30m | 0.13% $ 631.1k | |
| Chief People Officer | less than a year | no data | no data | |
| SVP of Clinical Affairs | 5.1yrs | no data | no data | |
| Chief Reg. Off | 4.2yrs | no data | 0.081% $ 398.6k | |
| Chief Business Officer | less than a year | no data | no data | |
| Senior Vice President of Information Technology | 1.8yrs | no data | no data | |
| Senior VP of Biometric | less than a year | no data | no data | |
| Senior Vice President of Global Clinical Operations | less than a year | no data | no data | |
| EVP of Science and Technology | no data | no data | no data |
1.0yrs
Average Tenure
59yo
Average Age
Experienced Management: PROK's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$9.00m | no data | |
| Independent Director | 2.8yrs | US$413.10k | 0.038% $ 185.4k | |
| Independent Director | 2.3yrs | US$749.64k | 0% $ 0 | |
| Independent Director | 2.8yrs | US$421.10k | 0% $ 0 | |
| Independent Director | 2.8yrs | US$423.60k | 0% $ 0 | |
| Independent Director | no data | US$410.60k | 0.023% $ 115.5k | |
| Chairman of the Board | no data | US$434.10k | 17.67% $ 87.1m | |
| Independent Director | no data | US$404.60k | 0% $ 0 |
2.8yrs
Average Tenure
61yo
Average Age
Experienced Board: PROK's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.